Skip to main content
Premium Trial:

Request an Annual Quote

UNC Institute to Use InforSense Software for PGx Programs

NEW YORK (GenomeWeb News) - The University of North Carolina at Chapel Hill has licensed InforSense's workflow-based analytics platform for use in pharmacogenomics research projects, the company said yesterday.
 
The Institute of Pharmacogenomics and Individualized Therapy at UNC-CH will use the GenSense software in its efforts to develop "precise, effective treatment options for individual patients suffering from a wide range of conditions," InforSense said.
 
The institute is focused on identifying genetic variants that may predispose patients to severe side effects or poor response to certain drugs.
 
The company said the GenSense software will enable IPIT to "leverage expression data, DNA and micoarray analysis, electronic medical records, and various relational databases to drive its interdisciplinary research initiatives."
 
Financial terms of the agreement were not released.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.